We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Deutsch Foundation-Sponsored Work Offers Multi-Pronged Attack on Major Medical Problem

Researchers create a microfluidic “lab on a chip” that uses light to monitor biofilm formation and biofilm response to drugs, detects growth and thickening of biofilms by monitoring translucency.
News

SSB and G-Con Manufacturing Announce Global Collaboration

Collaboration will support faster and more flexible facility construction and shortened time to market.
News

MGB Biopharma and Almac Collaborate on Contract Manufacturing Project

Almac to manufacture the production of the gram positive antibacterial compound MGB-BP3.
News

Pherecydes Pharma Secures DGA Funding

French defence procurement agency invests EUR 900,000 towards a Pherecydes Pharma managed EUR 1.2-million project.
News

PBL Awarded Pioneering US Patent on RNAi

The United States Patent and Trademark Office (USPTO) has issued out US Patent, with fundamental claims directed to methods of gene silencing in many organisms.
News

Courtagen Life Sciences Acquires Medicinal Genomics

Medicinal Genomics, as a wholly owned subsidiary of Courtagen, will apply next-generation sequencing technologies to better understand and elucidate the medical properties of Cannabis.
News

Researchers Use Sugar to Halt Esophageal Cancer in Its Track

The findings, reported in the journal Nature Medicine, have important implications for patients and may help to monitor their condition and prevent the development of cancer.
News

SpineSmith Adds Talented Scientist to Research and Development Team

The Celling Biosciences company, that designs, develops and markets innovative technologies in the field of regenerative medicine, is pleased to announce the addition of Dr. Matthew Murphy to its team of PhDs.
News

Leading Romanian Research Institution Expands Capabilities With Purchase of a NanoInk DPN 5000 System

The DPN 5000 System will be used for supramolecular structure fabrication, molecular recognition and self-assembling process applications.
News

Stellar Biotechnologies Announces Investor Relations Agreement

Stellar Biotechnologies, Inc. is pleased to announce that it has retained TheBiotechPanel, Inc. to provide the Company with investor relations services, for an initial period of six months.
Advertisement